vs

Side-by-side financial comparison of VAALCO ENERGY INC (EGY) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

VAALCO ENERGY INC is the larger business by last-quarter revenue ($91.0M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -25.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -4.7%).

VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

EGY vs PBYI — Head-to-Head

Bigger by revenue
EGY
EGY
1.2× larger
EGY
$91.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+52.9% gap
PBYI
27.7%
-25.2%
EGY
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-4.7%
EGY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EGY
EGY
PBYI
PBYI
Revenue
$91.0M
$75.5M
Net Profit
$-58.6M
Gross Margin
69.3%
Operating Margin
-71.3%
22.7%
Net Margin
-64.4%
Revenue YoY
-25.2%
27.7%
Net Profit YoY
-602.5%
EPS (diluted)
$-0.56
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EGY
EGY
PBYI
PBYI
Q4 25
$91.0M
$75.5M
Q3 25
$61.0M
$54.5M
Q2 25
$96.9M
$52.4M
Q1 25
$110.3M
$46.0M
Q4 24
$121.7M
$59.1M
Q3 24
$140.3M
$80.5M
Q2 24
$116.8M
$47.1M
Q1 24
$100.2M
$43.8M
Net Profit
EGY
EGY
PBYI
PBYI
Q4 25
$-58.6M
Q3 25
$1.1M
$8.8M
Q2 25
$8.4M
$5.9M
Q1 25
$7.7M
$3.0M
Q4 24
$11.7M
Q3 24
$11.0M
$20.3M
Q2 24
$28.2M
$-4.5M
Q1 24
$7.7M
$-4.8M
Gross Margin
EGY
EGY
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
EGY
EGY
PBYI
PBYI
Q4 25
-71.3%
22.7%
Q3 25
1.5%
17.6%
Q2 25
17.7%
12.7%
Q1 25
23.7%
8.7%
Q4 24
32.7%
22.6%
Q3 24
31.4%
27.4%
Q2 24
17.5%
-4.6%
Q1 24
32.1%
-5.3%
Net Margin
EGY
EGY
PBYI
PBYI
Q4 25
-64.4%
Q3 25
1.8%
16.2%
Q2 25
8.6%
11.2%
Q1 25
7.0%
6.5%
Q4 24
9.6%
Q3 24
7.8%
25.2%
Q2 24
24.1%
-9.6%
Q1 24
7.7%
-11.0%
EPS (diluted)
EGY
EGY
PBYI
PBYI
Q4 25
$-0.56
$0.26
Q3 25
$0.01
$0.17
Q2 25
$0.08
$0.12
Q1 25
$0.07
$0.06
Q4 24
$0.12
$0.40
Q3 24
$0.10
$0.41
Q2 24
$0.27
$-0.09
Q1 24
$0.07
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EGY
EGY
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$58.9M
$97.5M
Total DebtLower is stronger
$60.0M
$22.7M
Stockholders' EquityBook value
$443.5M
$130.3M
Total Assets
$913.4M
$216.3M
Debt / EquityLower = less leverage
0.14×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EGY
EGY
PBYI
PBYI
Q4 25
$58.9M
$97.5M
Q3 25
$24.0M
$94.4M
Q2 25
$67.9M
$96.0M
Q1 25
$40.9M
$93.2M
Q4 24
$82.7M
$101.0M
Q3 24
$89.1M
$96.7M
Q2 24
$62.9M
$96.8M
Q1 24
$113.3M
$107.2M
Total Debt
EGY
EGY
PBYI
PBYI
Q4 25
$60.0M
$22.7M
Q3 25
$60.0M
$34.0M
Q2 25
$60.0M
$45.3M
Q1 25
$0
$56.7M
Q4 24
$0
$68.0M
Q3 24
$0
$79.3M
Q2 24
$0
$90.7M
Q1 24
$0
$102.0M
Stockholders' Equity
EGY
EGY
PBYI
PBYI
Q4 25
$443.5M
$130.3M
Q3 25
$505.9M
$115.3M
Q2 25
$511.6M
$104.7M
Q1 25
$504.1M
$97.1M
Q4 24
$501.6M
$92.1M
Q3 24
$501.0M
$71.1M
Q2 24
$493.6M
$48.5M
Q1 24
$472.6M
$51.0M
Total Assets
EGY
EGY
PBYI
PBYI
Q4 25
$913.4M
$216.3M
Q3 25
$950.4M
$202.9M
Q2 25
$964.9M
$194.9M
Q1 25
$927.1M
$196.2M
Q4 24
$955.0M
$213.3M
Q3 24
$937.9M
$220.7M
Q2 24
$917.4M
$205.0M
Q1 24
$809.1M
$214.1M
Debt / Equity
EGY
EGY
PBYI
PBYI
Q4 25
0.14×
0.17×
Q3 25
0.12×
0.30×
Q2 25
0.12×
0.43×
Q1 25
0.00×
0.58×
Q4 24
0.00×
0.74×
Q3 24
0.00×
1.12×
Q2 24
0.00×
1.87×
Q1 24
0.00×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EGY
EGY
PBYI
PBYI
Operating Cash FlowLast quarter
$145.2M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EGY
EGY
PBYI
PBYI
Q4 25
$145.2M
$14.4M
Q3 25
$16.4M
$9.7M
Q2 25
$18.3M
$14.1M
Q1 25
$32.7M
$3.6M
Q4 24
$44.5M
$15.6M
Q3 24
$47.8M
$11.0M
Q2 24
$-438.0K
$1.0M
Q1 24
$21.8M
$11.2M
Free Cash Flow
EGY
EGY
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$29.7M
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
EGY
EGY
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
26.9%
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
EGY
EGY
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
2.7%
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
EGY
EGY
PBYI
PBYI
Q4 25
Q3 25
14.94×
1.10×
Q2 25
2.19×
2.41×
Q1 25
4.23×
1.21×
Q4 24
3.82×
Q3 24
4.35×
0.54×
Q2 24
-0.02×
Q1 24
2.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EGY
EGY

Crude Oil Sales And Purchase Agreements$54.8M60%
Other$31.9M35%
Crude Oil$3.0M3%
Natural Gas Liquids Reserves$1.4M2%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons